2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid hydrochloride, 95.0%, 5g

6-(4-AMINO-4-METHYLPIPERIDIN-1-YL)-3-(2,3-DICHLOROPHENYL)PYRAZIN-2-AMINE, 95.0%, 50mg

4-Bromo-2,6-diethylpyridine, 95.0%, 250mg

(6-Chloro-2-methanesulfonyl-pyrimidin-4-yl)-cyclopropyl-amine, 2g

2-Chloro-6-nitrotoluene, 99.0%, 100g

5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid, 95.0%, 100mg

ISOMANGIFERIN, 95%, 25mg

Fase de planificación S40x/0,65 objetivo corregido al infinito

5-(Aminomethyl)-2-methylpyrimidin-4-amine hydrochloride, 95.0%, 250mg

Butanedioic acid, compd. with 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (1:1), 98.50%, 1g

BENZYL (4-FLUOROPIPERIDIN-4-YL)METHYLCARBAMATE HCL, 90.0%, 500mg

4-Thiazol-2-yl-piperidine, 95.0%, 1g

1-(4-Bromo-2-nitrophenyl)piperidine, 95+%, 1g